T1	Participants 136 190	stroke prevention in patients with atrial fibrillation
T2	Participants 0 62	Randomised, parallel-group, multicentre, multinational phase 2
T3	Participants 432 473	1,146 patients with AF and risk of stroke
T4	Participants 835 894	Mean age was 65 +/- 8.7 years and 64.4% were warfarin-na√Øve
